Departamento de Farmacología y Fisiología, Facultad de Ciencias de Salud y del Deporte, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, Zaragoza, Spain.
Curr Opin Lipidol. 2011 Jun;22(3):159-64. doi: 10.1097/MOL.0b013e3283462288.
To summarize currently available information about the mechanisms involved in liver fat accumulation.
The contribution of functional genomics approaches, such as those represented by high-throughput analysis and genetically modified mice, may envision a complex network involving fatty acid, triglyceride and phospholipid metabolisms and lipid droplet dynamics. Likewise, it may pose an exquisite regulation exerted through insulin, glucocorticoids, thyroid hormones, transcription factors and microRNAs, orchestrated with sexual differences and able to respond to environmental factors such as nutritional or viral influences among others.
The information gathered will facilitate further research to complete gaps of interacting pieces among regulators and new contributing agents emerging from high-throughput analyses. With this new paradigm, new biomarkers able to discriminate the progression of hepatic steatosis into human steatohepatitis will eventually emerge, and hopefully new therapeutic approaches will be developed.
总结目前有关肝脂肪堆积相关机制的信息。
功能基因组学方法的贡献,如高通量分析和基因修饰小鼠所代表的方法,可以想象涉及脂肪酸、甘油三酯和磷脂代谢以及脂滴动力学的复杂网络。同样,它可能通过胰岛素、糖皮质激素、甲状腺激素、转录因子和 microRNAs 发挥精细调节,与性别差异有关,并能够对环境因素(如营养或病毒等)做出反应。
收集的信息将有助于进一步研究,以完成调控因子和高通量分析中出现的新的促发因子之间相互作用的空白。有了这个新的范例,最终将出现能够区分肝脂肪变性进展为人类脂肪性肝炎的新生物标志物,并有望开发出新的治疗方法。